SavedAdd your journal

Journals / Güncel Retina Dergisi / 2021 / Cilt: 5 - Sayı: 1

Vogt-Koyanagi-Harada Disease

Vogt-Koyanagi-Harada Hastalığı

Pınar ÇAKAR ÖZDAL
Pages
56–64
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although it is a severe disease with several complications, the visual prognosis is good if treated promptly and aggressively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vogt-Koyanagi-Harada (VKH) is a multisystem autoimmune disease characterized by bilateral, diffuse granulomatous uveitis associated with neurological, auditory and integumentary findings.
📊
Key Findings & Data:Multimodal imaging is crucial for both the initial diagnosis and monitoring the treatment response.
💡
Conclusion & Impact:Although it is a severe disease with several complications, the visual prognosis is good if treated promptly and aggressively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Vogt-Koyanagi-Harada (VKH) is a multisystem autoimmune disease characterized by bilateral, diffuse granulomatous uveitis associated with neurological, auditory and integumentary findings. Multimodal imaging is crucial for both the initial diagnosis and monitoring the treatment response. Although it is a severe disease with several complications, the visual prognosis is good if treated promptly and aggressively.

Özet

Vogt-Koyanagi-Harada (VKH) hastalığı bilateral, diffüz granülomatöz üveite eşlik eden nörolojik, işitsel ve cilt bulgularıyla karakterize mültisistemik otoimmün bir hastalıktır. Multimodal görüntüleme hem ilk tanının konması, hem de tedavi cevabının monitorizasyonunda çok önemli bir yere sahiptir. VKH çok sayıda komplikasyona yol açan ağır bir hastalık olsa da, erken ve agresif tedavi ile görme prognozu iyidir.

🔖

Cite This Article

ÖZDAL, P. Ç. (2021). Vogt-Koyanagi-Harada Disease. Güncel Retina Dergisi, Cilt: 5 - Sayı: 1, 56–64. https://ajindex.com/articles/224233

References (14)

  1. Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016; 52:84-111
  2. Greco A, Fusconi M, Gallo A, Turchetta R, Marinelli C, Macri GF, et al. Vogt-Koyanagi-Harada syndrome. Autoimmun Rev. 2013;12(11):1033-8
  3. Otani S, Sakurai T, Yamamoto K, Fujita T, Matsuzaki Y, Goto Y, et al. Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease. British journal of ophthalmology. 2006;90(6):773-7
  4. Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada’s disease. Current eye research. 2001;22(4):312-8
  5. Bassili SS, Peyman GA, Gebhardt BM, Daun M, Ganiban GJ, Rifai A. Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome. Retina. 1996; 16(2): 160-1
  6. Ozdal P, Ozdamar Y, Yazici A, Teke MY, Ozturk F. Vogt-Koyanagi-Harada disease: Clinical and demographic characteristics of patients in a specialized eye hospital in Turkey. Ocul Immunol Inflamm 2014; 22(4):277-86
  7. Yalçındağ FN, Özdal PC, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I; BUST Study Group. Demographic and clinical characteristics of uveitis in Turkey: The First National Registry Report. Ocul Immunol Inflamm. 2018; 26(1): 17-26
  8. Tugal-Tutkun I, Ozyazgan Y, Akova YA, Sullu Y, Akyol N, Soylu M, et al. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol. 2007; 27(2-3): 117–23
  9. Baltmr A, Lightman S, Tomkins-Netzer O. Vogt-Koyanagi-Harada syndrome - current perspectives. Clin Ophthalmol. 2016; 10: 2345-61
  10. Yang, P, Ren Y, Li B, Fang,W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 2007; 114(3): 606-14
  11. O’Keefe GA, Rao NA. Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 2017; 62(1):1-25
  12. Yang P, Liu X, Zhou H, Guo W, Zhou C, Kijlstra A. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset. Clin Experiment Ophthalmol 2011; 39(7): 639-47
  13. Herbort Jr CP, Abu El Asrar AM, Yamamoto JH, Pavésio CE, Gupta V, Khairallah M, et al. Reappraisal of the management of Vogt–Koyanagi– Harada disease: sunset glow fundus is no more a fatality. Int Ophthalmol 2017; 37(6): 1383-95
  14. Rao NA, Gupta A, Dustin L, Chee SP, Okada AA, Khairallah M et al. Frequency of distinguishing clinical features in Vogt